Sepe, Romina
Sepe, Romina
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
The long non-coding RNA prader willi/angelman region RNA5 (PAR5) is downregulated in anaplastic thyroid carcinomas where it acts as a tumor suppressor by reducing EZH2 activity
2020 Pellecchia S.; Sepe R.; DecaussinPetrucci M.; Ivan C.; Shimizu M.; Coppola C.; Testa D.; Calin G.A.; Fusco A.; Pallante P.
A ceRNA circuitry involving the long noncoding RNA KLHL14-AS, PAX8, and BCL2 drives thyroid carcinogenesis
2019 Credendino S.C.; Bellone M.L.; Lewin N.; Amendola E.; Sanges R.; Basu S.; Sepe R.; DecaussinPetrucci M.; Tinto N.; Fusco A.; de Felice M.; de Vita G.
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients.
2019 Capo A; Sepe R; Pellino G; Milone M; Malapelle U; Pellecchia S; Pepe F; Cacciola NA; Manigrasso M; Bruzzaniti S; Sciaudone G; De Palma GD; Galgani M; Selvaggi F; Troncone G; Fusco A; D'Auria S; Pallante P.
The metallophosphoesterase-domain-containing protein 2 (MPPED2) gene acts as tumor suppressor in breast cancer
2019 Pellecchia, S; Sepe, R; Federico, A; Cuomo, M; Credendino, Sc; Pisapia, P; Bellevicine, C; Nicolauneto, P; Ramundo, Ms; Crescenzi, E; de Vita, G; Terracciano, Lm; Chiariotti, L; Fusco, A; Pallante, P
The long non-coding RNA RP5-1024C24.1 and its associated-gene MPPED2 are down-regulated in human thyroid neoplasias and act as tumour suppressors
2018 Sepe, R; Pellecchia, S; Serra, P; D'Angelo, D; Federico, A; Raia, M; Penha, Rcc; Decaussinpetrucci, M; Vecchio, Ld; Fusco, A; Pallante, P
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.
2017 Quintavalle, Cristina; Burmeister, Katharina; Piscuoglio, Salvatore; Quagliata, Luca; Karamitopoulou, Eva; Sepe, Romina; Fusco, Alfredo; Terracciano Luigi, M; Andersen Jesper, B; Pallante, Pierlorenzo; Matter Matthias, S
HMGA1 overexpression is associated with a particular subset of human breast carcinomas
2016 Sepe, R; Piscuoglio, S; Quintavalle, C; Perrina, V; Quagliata, L; Formisano, U; Terracciano, Lm; Fusco, A; Pallante, P
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients
2016 Cacciola, Na; Calabrese, C; Malapelle, U; Pellino, G; De Stefano, A; Sepe, R; Sgariglia, R; Quintavalle, C; Federico, A; Bianco, A; Uchimura Bastos, A; Milone, M; Bellevicine, C; Milone, F; Carlomagno, C; Selvaggi, F; Troncone, G; Fusco, A; Pallante, P
UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines
2016 Palumbo A.; Da Costa N.M.; De Martino M.; Sepe R.; Pellecchia S.; Leite de Sousa V.P.; Neto P.N.; Kruel C.D.; Bergman A.; Nasciutti L.E.; Fusco A.; Pinto L.F.R.
High mobility group a proteins as tumor markers.
2015 Pallante, Pierlorenzo; Sepe, Romina; Puca, Francesca; Fusco, Alfredo
KRAS Mutant Allele-Specific Imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.
2015 Malapelle U; Sgariglia R; De Stefano A; Bellevicine C; Vigliar E; de Biase D; Sepe R; Pallante P; Carlomagno C; Tallini G; Troncone G.
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration
2015 Chiappetta, Gennaro; Valentino, Teresa; Vitiello, Michela; Pasquinelli, Rosa; Monaco, Mario; Palma, Giuseppe; Sepe, Romina; Luciano, Antonio; Pallante, Pierlorenzo; Palmieri, Dario; Aiello, Concetta; Rea, Domenica; Losito, Simona Nunzia; Arra, Claudio; Fusco, Alfredo; Fedele, Monica
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment
2015 Cacciola N.A.; Sepe R.; Forzati F.; Federico A.; Pellecchia S.; Malapelle U.; de Stefano A.; Rocco D.; Fusco A.; Pallante P.
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias
2015 Leone V.; Ferraro A.; Schepis F.; Federico A.; Sepe R.; Arra C.; Langella C.; Palma G.; De Lorenzo C.; Troncone G.; Masciullo V.; Scambia G.; Fusco A.; Pallante P.
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
2015 Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P.
CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hurthle Cell Adenomas and Carcinomas).
2014 Monaco, Mario; Chiappetta, Gennaro; Aiello, Concetta; Federico, Antonella; Sepe, Romina; Russo, Daniela; Fusco, Alfredo; Pallante, Pierlorenzo
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation.
2014 Forzati, F; Federico, A; Pallante, P; Colamaio, M; Esposito, F; Sepe, R; Gargiulo, S; Luciano, A; Arra, C; Palma, G; Bon, G; Bucher, S; Falcioni, R; Brunetti, A; Battista, S; Fedele, M; Fusco, A
CBX7 Modulates the Expression of Genes Critical for Cancer Progression
2014 Pallante, Pierlorenzo; Sepe, Romina; Federico, Antonella; Forzati, Floriana; Bianco, Mimma; Fusco, Alfredo
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration.
2014 Chiappetta, G; Valentino, T; Vitiello, M; Pasquinelli, R; Monaco, M; Palma, G; Sepe, R; Luciano, A; Pallante, P; Palmieri, D; Aiello, C; Rea, D; Losito, Sn; Arra, C; Fusco, A; Fedele, M
CBX7 is a tumor suppressor in mice and humans
2012 Forzati, Floriana; Federico, Antonella; Pallante, Pierlorenzo Lorenzo; Abbate, Adele; Esposito, Francesco; Malapelle, Umberto; Sepe, Romina; Palma, Giuseppe; Troncone, Giancarlo Carlo; Scarfò, Marzia; Arra, Claudio; Fedele, Monica; Fusco, Alfredo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The long non-coding RNA prader willi/angelman region RNA5 (PAR5) is downregulated in anaplastic thyroid carcinomas where it acts as a tumor suppressor by reducing EZH2 activity | 1-gen-2020 | Pellecchia S.; Sepe R.; DecaussinPetrucci M.; Ivan C.; Shimizu M.; Coppola C.; Testa D.; Calin G.A.; Fusco A.; Pallante P. | |
| A ceRNA circuitry involving the long noncoding RNA KLHL14-AS, PAX8, and BCL2 drives thyroid carcinogenesis | 1-gen-2019 | Credendino S.C.; Bellone M.L.; Lewin N.; Amendola E.; Sanges R.; Basu S.; Sepe R.; DecaussinPetrucci M.; Tinto N.; Fusco A.; de Felice M.; de Vita G. | |
| Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients. | 1-gen-2019 | Capo A; Sepe R; Pellino G; Milone M; Malapelle U; Pellecchia S; Pepe F; Cacciola NA; Manigrasso M; Bruzzaniti S; Sciaudone G; De Palma GD; Galgani M; Selvaggi F; Troncone G; Fusco A; D'Auria S; Pallante P. | |
| The metallophosphoesterase-domain-containing protein 2 (MPPED2) gene acts as tumor suppressor in breast cancer | 1-gen-2019 | Pellecchia, S; Sepe, R; Federico, A; Cuomo, M; Credendino, Sc; Pisapia, P; Bellevicine, C; Nicolauneto, P; Ramundo, Ms; Crescenzi, E; de Vita, G; Terracciano, Lm; Chiariotti, L; Fusco, A; Pallante, P | |
| The long non-coding RNA RP5-1024C24.1 and its associated-gene MPPED2 are down-regulated in human thyroid neoplasias and act as tumour suppressors | 1-gen-2018 | Sepe, R; Pellecchia, S; Serra, P; D'Angelo, D; Federico, A; Raia, M; Penha, Rcc; Decaussinpetrucci, M; Vecchio, Ld; Fusco, A; Pallante, P | |
| High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy. | 1-gen-2017 | Quintavalle, Cristina; Burmeister, Katharina; Piscuoglio, Salvatore; Quagliata, Luca; Karamitopoulou, Eva; Sepe, Romina; Fusco, Alfredo; Terracciano Luigi, M; Andersen Jesper, B; Pallante, Pierlorenzo; Matter Matthias, S | |
| HMGA1 overexpression is associated with a particular subset of human breast carcinomas | 1-gen-2016 | Sepe, R; Piscuoglio, S; Quintavalle, C; Perrina, V; Quagliata, L; Formisano, U; Terracciano, Lm; Fusco, A; Pallante, P | |
| UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients | 1-gen-2016 | Cacciola, Na; Calabrese, C; Malapelle, U; Pellino, G; De Stefano, A; Sepe, R; Sgariglia, R; Quintavalle, C; Federico, A; Bianco, A; Uchimura Bastos, A; Milone, M; Bellevicine, C; Milone, F; Carlomagno, C; Selvaggi, F; Troncone, G; Fusco, A; Pallante, P | |
| UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines | 1-gen-2016 | Palumbo A.; Da Costa N.M.; De Martino M.; Sepe R.; Pellecchia S.; Leite de Sousa V.P.; Neto P.N.; Kruel C.D.; Bergman A.; Nasciutti L.E.; Fusco A.; Pinto L.F.R. | |
| High mobility group a proteins as tumor markers. | 1-gen-2015 | Pallante, Pierlorenzo; Sepe, Romina; Puca, Francesca; Fusco, Alfredo | |
| KRAS Mutant Allele-Specific Imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer. | 1-gen-2015 | Malapelle U; Sgariglia R; De Stefano A; Bellevicine C; Vigliar E; de Biase D; Sepe R; Pallante P; Carlomagno C; Tallini G; Troncone G. | |
| PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration | 1-gen-2015 | Chiappetta, Gennaro; Valentino, Teresa; Vitiello, Michela; Pasquinelli, Rosa; Monaco, Mario; Palma, Giuseppe; Sepe, Romina; Luciano, Antonio; Pallante, Pierlorenzo; Palmieri, Dario; Aiello, Concetta; Rea, Domenica; Losito, Simona Nunzia; Arra, Claudio; Fusco, Alfredo; Fedele, Monica | |
| Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment | 1-gen-2015 | Cacciola N.A.; Sepe R.; Forzati F.; Federico A.; Pellecchia S.; Malapelle U.; de Stefano A.; Rocco D.; Fusco A.; Pallante P. | |
| The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias | 1-gen-2015 | Leone V.; Ferraro A.; Schepis F.; Federico A.; Sepe R.; Arra C.; Langella C.; Palma G.; De Lorenzo C.; Troncone G.; Masciullo V.; Scambia G.; Fusco A.; Pallante P. | |
| UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients. | 1-gen-2015 | Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P. | |
| CBX7 Expression in Oncocytic Thyroid Neoplastic Lesions (Hurthle Cell Adenomas and Carcinomas). | 1-gen-2014 | Monaco, Mario; Chiappetta, Gennaro; Aiello, Concetta; Federico, Antonella; Sepe, Romina; Russo, Daniela; Fusco, Alfredo; Pallante, Pierlorenzo | |
| CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. | 1-gen-2014 | Forzati, F; Federico, A; Pallante, P; Colamaio, M; Esposito, F; Sepe, R; Gargiulo, S; Luciano, A; Arra, C; Palma, G; Bon, G; Bucher, S; Falcioni, R; Brunetti, A; Battista, S; Fedele, M; Fusco, A | |
| CBX7 Modulates the Expression of Genes Critical for Cancer Progression | 1-gen-2014 | Pallante, Pierlorenzo; Sepe, Romina; Federico, Antonella; Forzati, Floriana; Bianco, Mimma; Fusco, Alfredo | |
| PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. | 1-gen-2014 | Chiappetta, G; Valentino, T; Vitiello, M; Pasquinelli, R; Monaco, M; Palma, G; Sepe, R; Luciano, A; Pallante, P; Palmieri, D; Aiello, C; Rea, D; Losito, Sn; Arra, C; Fusco, A; Fedele, M | |
| CBX7 is a tumor suppressor in mice and humans | 1-gen-2012 | Forzati, Floriana; Federico, Antonella; Pallante, Pierlorenzo Lorenzo; Abbate, Adele; Esposito, Francesco; Malapelle, Umberto; Sepe, Romina; Palma, Giuseppe; Troncone, Giancarlo Carlo; Scarfò, Marzia; Arra, Claudio; Fedele, Monica; Fusco, Alfredo |